Diseases of the Cardiovascular System, Phase IIA

Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

Volunteers
Health Professionals

What is the purpose of this trial?

This first-in-patient phase 2a pilot study will assess the safety and tolerability of MW01-6-189WH (hereafter called MW189) in patients with Intracerebral Hemorrhage (ICH).

Trial with
Johns Hopkins University
Ages
18 years and older
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Michael Kampp

203.737.2073
michael.kampp@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Jessica Magid-Bernstein, MD, PhD
Assistant Professor of Neurology

Sub-Investigators

Caitlin Loomis, MD
Emily J. Gilmore, MD, FNCS, FACNS
Guido J. Falcone, MD, ScD, MPH
Jaehan Park
James A. Giles, MD, PhD, MPHS, MRCP
Jennifer Ahjin Kim, MD/PhD
Jorge Rodriguez
Kevin Sheth, MD
Lauren Hachmann Sansing, MD, MS, FAHA, FANA
Mark Warman, MD, MSc, MA
Morgan Lippitt Prust, MD
N. Abimbola Sunmonu, MD/PhD
Syed Ali

Last Updated
07/02/2024
Study HIC
#2000031665